Novo Nordisk A/S (NVO) Stock News Today: Latest Update & Analysis - ABBO News

Evotec and Novo Nordisk (NYSE: NVO) Form Technology Development Partnership for Stem Cell Therapies

Edward Cooke / 26 September 2024

Evotec (NASDAQ: EVO), the German drug and development company, has entered into a technology development partnership with Novo Nordisk (NYSE: […]

Zabih Ullah / 24 September 2024

WASHINGTON – On Tuesday, U.S. Senator Bernie Sanders said he had commitments from the nation’s top pharmacy benefit managers that

Mark Glenn / 23 September 2024

Novo Nordisk’s (NYSE: NVO) chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the

The European Medicines Agency backed the use of Novo Nordisk’s (NYSE: NVO) popular drug Wegovy to help ease heart failure

Zabih Ullah / 18 September 2024

NEW YORK – On Wednesday, Hims & Hers Health (NYSE: HIMS), the U.S. telehealth company, said it will sell compounded

Novo Nordisk (NYSE: NVO), the Danish drugmaker, expects its diabetes drug Ozempic will “very likely” be on the U.S. government’s

Maria Reed / 17 September 2024

On Tuesday, U.S. Senator Bernie Sanders said he received confirmation from major generic pharmaceutical companies that they could sell copycat

The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business

Edward Cooke / 2 September 2024

Novo Nordisk (NYSE: NVO) said the shortage of lower strengths of its diabetes drug Ozempic has deteriorated, with intermittent shortages